{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "NRAS",
                "DNA Alteration": "c.181C>A",
                "GeneMutation": "p.Q61E Stopgain-LOF",
                "VariantAlleleFraction": "15.34%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1118A>G",
                "GeneMutation": "p.R248C Stopgain-LOF",
                "VariantAlleleFraction": "1.41%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.954G>T",
                "GeneMutation": "p.E318D Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "11.09%"
            },
            {
                "Gene": "PDGFRB",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.T681I Nonsense-GOF",
                "VariantAlleleFraction": "3.01%"
            },
            {
                "Gene": "HRAS",
                "DNA Alteration": "c.35G>T",
                "GeneMutation": "p.G12D Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "2.79%"
            },
            {
                "Gene": "PIK3CA",
                "DNA Alteration": "c.1635G>C",
                "GeneMutation": "p.C420R Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "7.25%"
            },
            {
                "Gene": "PDGFRA",
                "DNA Alteration": "c.1153_1154delinsTC",
                "GeneMutation": "p.K385X Nonsense-GOF",
                "VariantAlleleFraction": "7.65%"
            },
            {
                "Gene": "DPYD",
                "DNA Alteration": "c.2846A>T",
                "GeneMutation": "p.Y186C Stopgain-LOF",
                "VariantAlleleFraction": "6.81%"
            },
            {
                "Gene": "CHEK2",
                "DNA Alteration": "c.1283C>T",
                "GeneMutation": "p.I157T Spliceregionvariant-GOF",
                "VariantAlleleFraction": "6.0%"
            }
        ],
        "Germline": []
    }
}